They include caps on EpiPen prices, a ban on Styrofoam coolers and an expansion of who can authorize organ donations.
They include caps on EpiPen prices, a ban on Styrofoam coolers and an expansion of who can authorize organ donations.
inews.co.uk on MSN
The good health news that could improve your life in 2026
Medical progress has led to breakthroughs that could help people at every stage of life, from the smallest babies to the most ...
This 2026 Chevrolet Corvette ZR1 Coupe is a 3LZ ZTK example finished in Red Mist Metallic Tintcoat with Carbon Flash racing ...
Here are the top 5 AJMC.com articles and videos on allergy for 2025.
The fleet of race cars, each one a vibrant shade of green, blue, and yellow, shine under the sweltering sun and create a ...
Investing.com -- Amneal Pharmaceuticals Inc Class A (NASDAQ:AMRX) stock rose 2.8% in after-hours trading Tuesday following the FDA approval of the company’s epinephrine injection USP, expanding its ...
Amneal said that the Food and Drug Administration has approved its epinephrine injection in both single and multi-dose vials for hospitals. The Bridgewater, NJ-based biopharmaceutical company said ...
An update from Grand Pharmaceutical Group Limited ( ($HK:0512) ) is now available. Grand Pharmaceutical Group has entered into a product ...
neffy is commercially available in the U.S. for the emergency treatment of allergic reactions, including anaphylaxis, in ...
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback